Press Releases

More COVID-19 News

September 15, 2020

Updated: The Effects of COVID-19 on IAVI Clinical Programs

Updated September 15, 2020

July 21, 2020

Surveying the HIV Vaccine and Cure Landscape at AIDS 2020 Virtual

Thumbi Ndung'u, Ph.D., provides a view of current strategies for HIV vaccine and cure design

June 15, 2020

Powerful antibodies isolated from recovered donors protect against COVID-19 disease in an animal model

Findings offer promise for accelerated development of antibody-based prevention and treatment for COVID-19

June 5, 2020

Exploring the links between HIV and TB research and COVID-19

Summarizing the impact of COVID-19 on ongoing HIV and TB prevention research

June 3, 2020

Watch IAVI Experts Discuss Accelerating COVID-19 Vaccine Development with Merck

Mark Feinberg and Swati Gupta introduce viewers to the COVID-19 vaccine candidate, which uses the same technology as Merck’s Ebola vaccine.

May 27, 2020

Webinar Series Explores Community Engagement During COVID-19 and Beyond

Seventh edition of webinar series tackles community engagement in a time of social distancing.

May 26, 2020

IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2

New collaboration to leverage complementary expertise and capabilities with rVSV technology to advance novel vaccine candidate

April 23, 2020


Japan's commitment to contribute to the World Bank for COVID-19 vaccine research sets example and will advance global health, IAVI says (in Japanese).

April 22, 2020

Japan's Commitment to Contribute to the World Bank for COVID-19 Vaccine Research Sets Example and Will Advance Global Health, IAVI Says

Government of Japan, in partnership with the World Bank, commits funds to COVID-19 vaccine development.

March 30, 2020

The Effects of COVID-19 on IAVI Clinical Programs

IAVI's response to the COVID-19 pandemic


Media Contacts


Ethel Makila
+254 71 904 3142 



Hester Kuipers
+31 20 521 0343 



Saif ul Hadi
+91 11 4737 6032 


North America

Rose Catlos
+1 212 847 1049